166 related articles for article (PubMed ID: 37659962)
1. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A; Heidegger I; Virk RK; Di Bernardo M; Kim JY; Laplaca C; Picech F; Schäfer G; De Castro GJ; Hibshoosh H; Loda M; Klocker H; Rubin MA; Zheng T; Benson MC; McKiernan JM; Dutta A; Abate-Shen C
Eur Urol; 2024 Apr; 85(4):361-372. PubMed ID: 37659962
[TBL] [Abstract][Full Text] [Related]
2. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C
Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453
[TBL] [Abstract][Full Text] [Related]
3. NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.
Papachristodoulou A; Rodriguez-Calero A; Panja S; Margolskee E; Virk RK; Milner TA; Martina LP; Kim JY; Di Bernardo M; Williams AB; Maliza EA; Caputo JM; Haas C; Wang V; De Castro GJ; Wenske S; Hibshoosh H; McKiernan JM; Shen MM; Rubin MA; Mitrofanova A; Dutta A; Abate-Shen C
Cancer Discov; 2021 Sep; 11(9):2316-2333. PubMed ID: 33893149
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Mediated Point Mutation in
Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
[No Abstract] [Full Text] [Related]
5. Prostate Cancer-specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users.
Joentausta RM; Rannikko A; Murtola TJ
Eur Urol Open Sci; 2021 Dec; 34():86-93. PubMed ID: 34934970
[TBL] [Abstract][Full Text] [Related]
6. Nkx3.1 controls the DNA repair response in the mouse prostate.
Zhang H; Zheng T; Chua CW; Shen M; Gelmann EP
Prostate; 2016 Mar; 76(4):402-8. PubMed ID: 26660523
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of loss of
Le Magnen C; Virk RK; Dutta A; Kim JY; Panja S; Lopez-Bujanda ZA; Califano A; Drake CG; Mitrofanova A; Abate-Shen C
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266798
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.
Martinez EE; Anderson PD; Logan M; Abdulkadir SA
PLoS One; 2012; 7(10):e46792. PubMed ID: 23077524
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells.
Matsuda C; Ishii K; Nakagawa Y; Shirai T; Sasaki T; Hirokawa YS; Iguchi K; Watanabe M
J Cell Biochem; 2023 Aug; 124(8):1135-1144. PubMed ID: 37334663
[TBL] [Abstract][Full Text] [Related]
11. PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance.
Lokman U; Erickson AM; Vasarainen H; Rannikko AS; Mirtti T
Eur Urol Focus; 2018 Dec; 4(6):867-873. PubMed ID: 28753869
[TBL] [Abstract][Full Text] [Related]
12. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma.
Mehreen A; Manjee KG; Paralkar D; Paner GP; Lan T
Adv Anat Pathol; 2024 May; 31(3):202-205. PubMed ID: 38525603
[TBL] [Abstract][Full Text] [Related]
13. NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.
Locke JA; Zafarana G; Ishkanian AS; Milosevic M; Thoms J; Have CL; Malloff CA; Lam WL; Squire JA; Pintilie M; Sykes J; Ramnarine VR; Meng A; Ahmed O; Jurisica I; van der Kwast T; Bristow RG
Clin Cancer Res; 2012 Jan; 18(1):308-16. PubMed ID: 22048240
[TBL] [Abstract][Full Text] [Related]
14. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
16. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
17. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
18. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
[TBL] [Abstract][Full Text] [Related]
19. Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.
Ornstein DK; Cinquanta M; Weiler S; Duray PH; Emmert-Buck MR; Vocke CD; Linehan WM; Ferretti JA
J Urol; 2001 Apr; 165(4):1329-34. PubMed ID: 11257711
[TBL] [Abstract][Full Text] [Related]
20. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Martinez EE; Darke AK; Tangen CM; Goodman PJ; Fowke JH; Klein EA; Abdulkadir SA
Cancer Prev Res (Phila); 2014 Sep; 7(9):950-7. PubMed ID: 24894197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]